Stockreport

AN2 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business and Scientific Highlights [Yahoo! Finance]

AN2 Therapeutics, Inc.  (ANTX) 
US:NYSE Investor Relations: ir.antheminc.com
PDF MENLO PARK, Calif., August 13, 2024 BUSINESS WIRE )--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel smal [Read more]